These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26782675)

  • 21. Azithromycin compared with minocycline in the treatment of acne comedonica and papulo-pustulosa.
    Gruber F; Grubisić-Greblo H; Kastelan M; Brajac I; Lenković M; Zamolo G
    J Chemother; 1998 Dec; 10(6):469-73. PubMed ID: 9876055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solodyn (Minocycline HCl, USP) extended-release tablets.
    Gupta AK; Gover MD; Abramovits W; Perlmutter A
    Skinmed; 2006; 5(6):291-2. PubMed ID: 17085996
    [No Abstract]   [Full Text] [Related]  

  • 23. Minocycline in acne vulgaris: benefits and risks.
    Ochsendorf F
    Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriatic arthritis and minocycline induced autoantibodies.
    Leitch DN; Haslock DI
    Clin Rheumatol; 1997 May; 16(3):317-8. PubMed ID: 9184273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefit-risk assessment of acne therapies.
    Seukeran DC; Eady EA; Cunliffe WJ
    Lancet; 1997 Apr; 349(9060):1251-2. PubMed ID: 9130967
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris.
    Grosshans E; Belaïch S; Meynadier J; Alirezai M; Thomas L
    Eur J Dermatol; 1998; 8(3):161-6. PubMed ID: 9649660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minocycline toxicity requiring liver transplant.
    Losanoff JE; Holder-Murray JM; Ahmed EB; Cochrane AB; Testa G; Millis JM
    Dig Dis Sci; 2007 Nov; 52(11):3242-4. PubMed ID: 17404879
    [No Abstract]   [Full Text] [Related]  

  • 28. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus.
    Margolis DJ; Hoffstad O; Bilker W
    Br J Dermatol; 2007 Sep; 157(3):540-6. PubMed ID: 17596147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minocycline induced lupus and autoimmune hepatitis.
    Colmegna I; Perandones CE; Chaves JG
    J Rheumatol; 2000 Jun; 27(6):1567-8. PubMed ID: 10852297
    [No Abstract]   [Full Text] [Related]  

  • 30. Benefit-risk assessment of acne therapies.
    Bénéton N; Bocquet H; Cosnes A; Revuz J; Roujeau JC
    Lancet; 1997 Apr; 349(9060):1252. PubMed ID: 9130968
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety and efficacy of a new extended-release formulation of minocycline.
    Fleischer AB; Dinehart S; Stough D; Plott RT; ;
    Cutis; 2006 Oct; 78(4 Suppl):21-31. PubMed ID: 17436826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minocycline hepatitis.
    Ford TJ; Dillon JF
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):796-9. PubMed ID: 18617786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minocycline-induced polyarteritis nodosa-like vasculitis.
    Agur T; Levy Y; Plotkin E; Benchetrit S
    Isr Med Assoc J; 2014 May; 16(5):322-3. PubMed ID: 24979843
    [No Abstract]   [Full Text] [Related]  

  • 34. [Minocycline-induced autoimmune hepatitis].
    Aldenhoven M; van Enk JG; Avis WA
    Ned Tijdschr Geneeskd; 2013; 157(3):A5465. PubMed ID: 23328022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stomatitis, glossitis, and esophagitis in a patient treated with minocycline].
    Heidrich H
    Med Klin (Munich); 2004 Jul; 99(7):396-7. PubMed ID: 15322719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-ranging efficacy of new once-daily extended-release minocycline for acne vulgaris.
    Stewart DM; Torok HM; Weiss JS; Plott RT;
    Cutis; 2006 Oct; 78(4 Suppl):11-20. PubMed ID: 17436825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication-associated depersonalization symptoms: report of transient depersonalization symptoms induced by minocycline.
    Cohen PR
    South Med J; 2004 Jan; 97(1):70-3. PubMed ID: 14746427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced hypersensitivity syndrome due to minocycline complicated by severe myocarditis.
    Kanno K; Sakai H; Yamada Y; Iizuka H
    J Dermatol; 2014 Feb; 41(2):160-2. PubMed ID: 24471460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse effects of minocycline in the treatment of acne vulgaris].
    Van Wayjen RG; Van den Ende A
    Ned Tijdschr Geneeskd; 1997 Oct; 141(40):1934-5. PubMed ID: 9550742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.